|
Baker Bros. Advisors Lp
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2025-12-11 |
$86.00 |
0.0% |
2,005,813
|
$172,499,918 |
|
Baker Bros. Advisors Lp
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2025-06-30 |
$44.00 |
0.0% |
655,500
|
$28,842,000 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2025-06-30 |
$44.00 |
0.0% |
317,167
|
$13,955,348 |
|
Baker Bros. Advisors Lp
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2024-08-20 |
$46.41 |
0.4% |
1
|
$46 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2023-11-03 |
$12.80 |
264.0% |
414,105
|
$5,301,325 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2023-01-12 |
$30.51 |
52.7% |
41,007
|
$1,251,191 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2022-08-22 |
$26.00 |
79.2% |
545,525
|
$14,183,650 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2022-05-27 |
$14.34 |
225.0% |
289,426
|
$4,150,321 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2022-05-20 |
$14.00 |
232.9% |
10,100
|
$141,394 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2022-05-06 |
$19.46 |
139.4% |
250,000
|
$4,865,365 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2022-01-31 |
$38.96 |
19.6% |
130,309
|
$5,076,473 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2022-01-24 |
$37.76 |
23.4% |
272,767
|
$10,300,637 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2021-07-01 |
$47.00 |
-0.9% |
544,166
|
$25,575,802 |